Sergey Yurasov

2023

In 2023, Sergey Yurasov earned a total compensation of $1.2M as Chief Medical Officer at Black Diamond Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$205,065
Option Awards$514,760
Salary$488,250
Other$25,609
Total$1,233,684

Yurasov received $514.8K in option awards, accounting for 42% of the total pay in 2023.

Yurasov also received $205.1K in non-equity incentive plan, $488.3K in salary and $25.6K in other compensation.

Rankings

In 2023, Sergey Yurasov's compensation ranked 977th out of 2,907 executives tracked by ExecPay. In other words, Yurasov earned more than 66.4% of executives.

ClassificationRankingPercentile
All
977
out of 2,907
66th
Division
Manufacturing
586
out of 1,599
63rd
Major group
Chemicals And Allied Products
401
out of 901
56th
Industry group
Drugs
390
out of 864
55th
Industry
Biological Products, Except Diagnostic Substances
120
out of 211
43rd
Source: SEC filing on April 24, 2024.

Yurasov's colleagues

We found three more compensation records of executives who worked with Sergey Yurasov at Black Diamond Therapeutics in 2023.

2023

Mark Velleca

Black Diamond Therapeutics

Chief Executive Officer

2023

David Epstein

Black Diamond Therapeutics

Chief Executive Officer

2023

Fang Ni

Black Diamond Therapeutics

Chief Financial Officer

News

You may also like